dazukibart (PF-06823859) / Pfizer  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dazukibart (PF-06823859) / Pfizer
NCT05895786: A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

Recruiting
3
270
Europe, Japan, US, RoW
PF-06823859, Placebo
Pfizer
Myositis
07/26
07/26

Download Options